logo

$5 And Under

Share SHARE

Extreme Networks Inc. (EXTR) announced after the bell Wednesday that it has agreed to acquire Brocade Communications Systems' data center networking business from Broadcom (AVGO) following the completion of their merger. Extreme is now up 0.95 on 38K shares. Extreme Networks declined during the second...

Agile Therapeutics Inc. (AGRX) has jumped in the last 10 minutes of trade on increased volume. The stock is now up 0.26 at $3.42. Agile Therapeutics has broken out of a week and a half long trading range this morning and has set nearly a 3-month high.

Tonix Pharmaceuticals Holding (TNXP) announced Wednesday morning that it will provide a corporate update and an overview of its posttraumatic stress disorder (PTSD) clinical program at The MicroCap Conference on April 4. Tonix Pharmaceuticals gapped open sharply higher this morning and has continued...

Catalyst Biosciences Inc. (CBIO) announced Tuesday morning that the Korean Ministry of Food and Drug Safety has approved its Investigational New Drug Application for CB 2679d/ISU304. Catalyst Biosciences gapped open higher Tuesday and rose sharply during the first hour of trade. The stock settled...

Catalyst Biosciences Inc. (CBIO) announced Tuesday morning that the Korean Ministry of Food and Drug Safety has approved its Investigational New Drug Application for CB 2679d/ISU304. Catalyst Biosciences gapped open sharply higher Tuesday and has spiked higher in early trade. Shares are now up 7.03...

Cellect Biotechnology Ltd. (APOP) announced Monday morning that the first stem cell transplant procedure has been successfully performed using its ApoGraft technology in its Phase I/II clinical trial in a blood cancer patient. Cellect Biotechnology gapped open higher Monday and spiked to the upside...

Systemax Inc. (SYX) announced early Monday that it agreed to sell all of its unprofitable European Technology Products Group businesses. Systemax has risen sharply in early trade this morning and is currently higher by 1.85 at $9.05. The stock has surged to a 2 1/2 week high and has re-crossed its...

Cellect Biotechnology Ltd. (APOP) announced Monday morning that the first stem cell transplant procedure has been successfully performed using its ApoGraft technology in its Phase I/II clinical trial in a blood cancer patient. Cellect Biotechnology gapped up at the open Monday and has spiked higher...

Xenon Pharmaceuticals Inc. (XENE) announced Friday morning that its Phase 2 study of XEN801 in patients with moderate to severe acne did not demonstrate a statistically significant difference from vehicle placebo in its primary endpoint. Xenon Pharmaceuticals gapped open dramatically lower Friday,...

HTG Molecular Diagnostics (HTGM) reported a fourth quarter net loss of $0.76 per share after the bell Thursday, compared to the loss of $0.83 per share last year. Revenue came in at $1.5 million, up from $1.2 million last year. HTG Molecular Diagnostics gapped open higher Friday and climbed during...

HTG Molecular Diagnostics (HTGM) reported a fourth quarter net loss of $0.76 per share after the bell Thursday, compared to the loss of $0.83 per share last year. Revenue came in at $1.5 million, up from $1.2 million last year. HTG Molecular Diagnostics gapped open higher Friday and has risen sharply...

Xenon Pharmaceuticals Inc. (XENE) announced Friday morning that its Phase 2 study of XEN801 in patients with moderate to severe acne did not demonstrate a statistically significant difference from vehicle placebo in its primary endpoint. Xenon Pharmaceuticals has gapped open dramatically lower this...

HTG Molecular Diagnostics (HTGM) announced after the bell Wednesday that it has obtained CE marking in the European Union for its HTG EdgeSeq ALKPlus Assay EU. The stock is now up 1.11 on 124K shares. HTG Molecular Diagnostics traded in a narrow range throughout Wednesday's session and closed up by 0.17 at $2.14.

Interpace Diagnostics Group (IDXG) gapped up slightly Wednesday and has risen sharply in early trade. Shares are now up 0.81 at $3.26 on above average volume. Interpace Diagnostics has jumped to a 1-month high and has re-crossed its 200-day moving average.

Cerulean Pharma Inc. (CERU) announced Monday morning that it has entered into a definitive stock purchase agreement with privately-held Daré Bioscience through which equityholders of Daré Bioscience will become the majority owners of Cerulean. Cerulean Pharma gapped open sharply lower Monday, but...

Follow RTT